Citiva and Epican cannabis extracts to be used in study on children with epilepsy in Jamaica
Citiva announced over the weekend that they are donating their first cannabis-based medicinal product to be used in a study that will examine its effect on children with epilepsy in Jamaica.
The research company will be conducting the study in partnership with the University of the West Indies, Mona; who they in July 2015, worked with to identify combinations of cannabinoids effective at treating specific diseases and symptoms.
The specialized, therapeutic, High-CBD cannabis strain was bred and cultivated by CITIVA at their horticulture center on the Mona campus.
“The University of the West Indies is proud to announce that our partnership with CITIVA is beginning to bear fruit. CITIVA has begun construction of a world leading medical cannabis research center in the medical sciences building on the Mona Campus. UWI plans to work closely with CITIVA on critical research that will benefit both the healthcare system and the people and economy of Jamaica.” said Professor Archibald McDonald, the Deputy Principal of the University of the West Indies at Mona.
The strain was then extracted into oil by Epican at their 5000 sq. ft., state-of-the-art facility in Kingston.
“As Jamaica moves forward to embrace the cannabis industry, we are pleased and honored to provide to CITIVA the most advanced technological extraction of phytocannabinoids, to ensure and guarantee that their finished products are accurately dosed, and of the highest standards of quality and purity, “ said Karibe McKenzie, Founder, and CEO of Epican.
CEO of CITIVA Kim Volman noted that while the concept of medical cannabis has been in Jamaica for centuries, se is hopeful that partnership will transform the concept into a job creator and an income earner.
“CITIVA is proud of the development of our facility on the Mona Campus of UWI. The concept of medical cannabis has been in Jamaica for centuries. This is the beginning of a partnership that we hope will create hundreds of jobs, crucial medications for the sick and disabled, and a dynamic new industry, said Volman.
Both companies have been engaged in local collaborative research agreements and are working toward the advancement of science, research, development, and marketing of effective cannabis-based products for a wide variety of health conditions.
CITIVA’s donation of medically-indicated products is set to be the first of many of their products that will be used in future studies in collaboration with UWI.
Epican, a Jamaican-owned and operated company is partnering with the Scientific Research Council with a focus on large-scale, CO2 extraction of phytocannabinoids and terpenes from the cannabis plant for medicinal purposes.